Samantha Hawes
Physician Assistant · Tempe, AZNPI 1902398167
Payments from drug & device makers
Across 71 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$178
- Boehringer Ingelheim$147
- Novo Nordisk$121
- AstraZeneca$116
- Lilly USA, LLC$113
- Novartis$85
- plus $629 from 20 others
What the payments were for
- Food & beverage$1,389100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $178 |
| Boehringer Ingelheim | 6 | $147 |
| Novo Nordisk | 7 | $121 |
| AstraZeneca | 8 | $116 |
| Lilly USA, LLC | 6 | $113 |
| Novartis | 4 | $85 |
| Amgen | 4 | $68 |
| Dexcom, Inc. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Edwards Lifesciences | 2 | $52 |
| Astellas Pharma US Inc | 2 | $47 |
| Pfizer | 2 | $41 |
| Exact Sciences | 2 | $31 |
| Medtronic | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Abbott | 1 | $24 |
| Sanofi | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Gilead | 1 | $20 |
| Nevro Corp. | 1 | $20 |
| AbbVie | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $12 |
How this compares
$1,389 in reported general payments places this provider in the 75th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $50,226 |
| JardianceEmpagliflozin | 34 | $45,417 |
| MounjaroTirzepatide | 27 | $32,477 |
| TrulicityDulaglutide | 18 | $26,690 |
| EliquisApixaban | 20 | $23,879 |
| TradjentaLinagliptin | 11 | $11,991 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $7,983 |
| Levothyroxine Sodium | 144 | $2,027 |
| Atorvastatin Calcium | 207 | $1,903 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,813 |
| Rosuvastatin Calcium | 128 | $1,798 |
| Tamsulosin Hcl | 73 | $1,410 |
| Pantoprazole Sodium | 47 | $1,227 |
| Esomeprazole Magnesium | 16 | $1,078 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 12 | $1,066 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $113 | $59,16745 claims |
| Boehringer IngelheimJardiance, Tradjenta | $147 | $57,40845 claims |
| Novo NordiskOzempic | $121 | $50,22644 claims |
| PfizerEliquis | $41 | $23,87920 claims |
| AbbVieSynthroid | $18 | $58212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Tempe
- Christopher BradshawTempe$16K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.